genOway Société anonyme (EPA:ALGEN)

genOway Société anonyme Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	23.05	21.54	18.36	15.79	12.83	10.42
Other Revenue	5.04	4.97	2.73	4	3.49	3.86
Revenue	28.08	26.51	21.09	19.79	16.31	14.28
Revenue Growth (YoY)	23.42%	25.70%	6.58%	21.30%	14.26%	-4.51%
Cost of Revenue	12.36	10.67	9.3	9.39	7.33	6.12
Gross Profit	15.72	15.84	11.79	10.4	8.98	8.16
Selling, General & Admin	9.58	9.2	8.04	8.22	7.16	6.8
Other Operating Expenses	0.6	0.82	0.75	0.95	0.87	0.75
Operating Expenses	14.46	14.27	11.3	11.1	9.32	8.73
Operating Income	1.26	1.57	0.49	-0.7	-0.34	-0.58
Interest Expense	-0.16	-0.11	-0.12	-0.27	-0.17	-0.25
Interest & Investment Income	0.15	0.02	0	0.25	0.1	0
Currency Exchange Gain (Loss)	0.06	0.09	0.14	-	-	-
Other Non Operating Income (Expenses)	0.03	0.01	-0.16	-	-	-
EBT Excluding Unusual Items	1.34	1.58	0.35	-0.72	-0.42	-0.82
Gain (Loss) on Sale of Investments	-0.03	-0.03	-0.04	-	-	-
Other Unusual Items	-0.09	0	0.45	0.37	-0.19	-0.15
Pretax Income	1.21	1.55	0.76	-0.35	-0.61	-0.97
Income Tax Expense	-0.04	-0.02	-0.02	-0.03	0.08	0.06
Net Income	1.26	1.57	0.78	-0.32	-0.69	-1.04
Net Income to Common	1.26	1.57	0.78	-0.32	-0.69	-1.04
Net Income Growth	-21.25%	101.55%	-	-	-	-
Gross Margin	55.98%	59.74%	55.92%	52.56%	55.07%	57.14%
Operating Margin	4.49%	5.90%	2.32%	-3.53%	-2.08%	-4.03%
Profit Margin	4.47%	5.91%	3.69%	-1.63%	-4.21%	-7.26%
EBITDA	5.54	5.81	3.01	0.52	0.88	0.61
EBITDA Margin	19.74%	21.93%	14.25%	2.64%	5.40%	4.24%
D&A For EBITDA	4.28	4.25	2.52	1.22	1.22	1.18
EBIT	1.26	1.57	0.49	-0.7	-0.34	-0.58
EBIT Margin	4.49%	5.90%	2.32%	-3.53%	-2.08%	-4.03%
Revenue as Reported	28.22	26.59	21.4	19.8	16.66	14.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.